Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zenas BioPharma (ZBIO) Other Non Operating Income (2023 - 2025)

Zenas BioPharma (ZBIO) has 3 years of Other Non Operating Income data on record, last reported at $1.1 million in Q3 2025.

  • For Q3 2025, Other Non Operating Income fell 54.54% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $11.0 million, up 134.37%, while the annual FY2024 figure was $8.2 million, 1210.1% up from the prior year.
  • Other Non Operating Income reached $1.1 million in Q3 2025 per ZBIO's latest filing, down from $3.0 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $3.6 million in Q1 2025 and bottomed at -$16000.0 in Q3 2023.
  • Average Other Non Operating Income over 3 years is $2.0 million, with a median of $2.1 million recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 14962.5% in 2024, then plummeted 54.54% in 2025.
  • A 3-year view of Other Non Operating Income shows it stood at -$16000.0 in 2023, then surged by 21650.0% to $3.4 million in 2024, then crashed by 68.65% to $1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $1.1 million in Q3 2025, $3.0 million in Q2 2025, and $3.6 million in Q1 2025.